The Motley Fool··Adria CiminoPfizer's 6.55% Dividend Faces Growth Questions as Patent Cliffs Loom
Pfizer's 6.55% dividend yield offers attractive income but reflects patent cliff and pandemic revenue decline pressures. Strategic restructuring and Seagen acquisition signal transformation bid.
PFEVRTXVKTXCRSPbiotechdividend sustainability